A Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
| Status: | Recruiting |
|---|---|
| Conditions: | Blood Cancer, Blood Cancer, Hematology |
| Therapuetic Areas: | Hematology, Oncology |
| Healthy: | No |
| Age Range: | 60 - Any |
| Updated: | 3/8/2019 |
| Start Date: | September 2016 |
| End Date: | December 2021 |
| Contact: | Areej El-Jawahri, MD |
| Phone: | 617-643-4003 |
Randomized Trial of a Collaborative Palliative and Oncology Care Model for Patients With Acute Myeloid Leukemia
This research study is evaluating the impact a collaborative palliative care and oncology
team will have on the quality of life, symptoms, mood, and end of life outcomes of patients
with acute myeloid leukemia (AML). Palliative care is a medical specialty focused on
lessening (or "palliating") symptoms and assisting in coping with serious illness.
team will have on the quality of life, symptoms, mood, and end of life outcomes of patients
with acute myeloid leukemia (AML). Palliative care is a medical specialty focused on
lessening (or "palliating") symptoms and assisting in coping with serious illness.
The main purpose of this study is to compare two types of care - standard leukemia oncology
care and standard leukemia oncology care with collaborative involvement of palliative care
clinicians to see which is better for improving the experience of patients and families with
AML undergoing treatment.
The investigators aim to find out whether introducing patients and families undergoing AML
treatment to the palliative care team that specializes in symptom management can improve the
physical and psychological symptoms that patients and families experience during their
hospitalizations for their leukemia care as well as enhance the quality of patients' end of
life care.
care and standard leukemia oncology care with collaborative involvement of palliative care
clinicians to see which is better for improving the experience of patients and families with
AML undergoing treatment.
The investigators aim to find out whether introducing patients and families undergoing AML
treatment to the palliative care team that specializes in symptom management can improve the
physical and psychological symptoms that patients and families experience during their
hospitalizations for their leukemia care as well as enhance the quality of patients' end of
life care.
Inclusion Criteria:
- Hospitalized patients with high-risk AML, defined as:
- Newly diagnosed patients with AML ≥ 60 years of age
- Newly diagnosed AML with antecedent hematologic disorder
- Newly diagnosed therapy-related AML
- Relapsed AML
- Primary refractory AML
Exclusion Criteria:
- Patients already receiving palliative care
- Major psychiatric illness or comorbid conditions prohibiting compliance with study
procedures.
- A diagnosis of acute promyelocytic leukemia (APML)
We found this trial at
3
sites
Durham, North Carolina 27710
(919) 684-8111
Principal Investigator: Thomas LeBlanc, MD
Phone: 919-684-8964
Duke University Younger than most other prestigious U.S. research universities, Duke University consistently ranks among...
Click here to add this to my saved trials
185 Cambridge Street
Boston, Massachusetts 02114
Boston, Massachusetts 02114
617-724-5200
Principal Investigator: Areej El-Jawahri, MD
Phone: 617-643-4003
Click here to add this to my saved trials
3451 Walnut St
Philadelphia, Pennsylvania 19104
Philadelphia, Pennsylvania 19104
1 (215) 898-5000
Phone: 800-789-7366
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
Click here to add this to my saved trials